000 01591 a2200409 4500
005 20250515064920.0
264 0 _c20070517
008 200705s 0 0 eng d
022 _a1744-7658
024 7 _a10.1517/13543784.16.5.569
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKonstantinopoulos, Panagiotis A
245 0 0 _aFocus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
_h[electronic resource]
260 _bExpert opinion on investigational drugs
_cMay 2007
300 _a569-71 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aHistone Acetyltransferases
_xmetabolism
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistone Deacetylases
_xmetabolism
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
700 1 _aKaramouzis, Michalis V
700 1 _aPapavassiliou, Athanasios G
773 0 _tExpert opinion on investigational drugs
_gvol. 16
_gno. 5
_gp. 569-71
856 4 0 _uhttps://doi.org/10.1517/13543784.16.5.569
_zAvailable from publisher's website
999 _c17010801
_d17010801